Skip to Main Content

Paper Details

Subclonal diversification of primary breast cancer revealed by multiregion sequencing.
Nat Med
570
2015
BRCA2, MYC, PIK3CA, PTEN, TP53, antecedent, breast cancer, breast cancer genes, cancer, cancer genomes, cancers, patient, patients, primary breast cancer, tumor, tumors
Author NameAffiliation
Moritz GerstungWellcome Trust Sanger Institute
Gunes GundemWellcome Trust Sanger Institute
Peter Van LooWellcome Trust Sanger Institute, University of Leuven
Ludmil B AlexandrovWellcome Trust Sanger Institute, Los Alamos National Laboratory
Ludmil B AlexandrovWellcome Trust Sanger Institute, Los Alamos National Laboratory
Manasa RamakrishnaWellcome Trust Sanger Institute
Serena Nik-ZainalWellcome Trust Sanger Institute
Stuart McLarenWellcome Trust Sanger Institute
Adam ButlerWellcome Trust Sanger Institute
Dominik GlodzikWellcome Trust Sanger Institute
Andrew MenziesWellcome Trust Sanger Institute
Keiran RaineWellcome Trust Sanger Institute
Jonathan HintonWellcome Trust Sanger Institute
David JonesWellcome Trust Sanger Institute
Laura MudieWellcome Trust Sanger Institute
Michael R StrattonWellcome Trust Sanger Institute
Christos SotiriouInstitut Jules Bordet, Universite Libre de Bruxelles
Andrea L Richardson1] Dana-Farber Cancer Institute, USA. [2] Brigham and Women's Hospital, Harvard Medical School
David C WedgeWellcome Trust Sanger Institute
Peter J CampbellWellcome Trust Sanger Institute
  • 1 - 20

Datasets

Release 1.2